Compare PROF & CNDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | CNDT |
|---|---|---|
| Founded | N/A | 2016 |
| Country | Canada | United States |
| Employees | N/A | 51000 |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.2M | 232.4M |
| IPO Year | 2017 | 2016 |
| Metric | PROF | CNDT |
|---|---|---|
| Price | $6.92 | $1.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 61.0K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | $16,098,000.00 | ★ $3,042,000,000.00 |
| Revenue This Year | $92.40 | $2.01 |
| Revenue Next Year | $64.10 | $4.06 |
| P/E Ratio | $35.95 | ★ N/A |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $3.92 | $1.15 |
| 52 Week High | $8.95 | $2.98 |
| Indicator | PROF | CNDT |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 62.77 |
| Support Level | $5.81 | $1.77 |
| Resistance Level | $7.07 | $2.07 |
| Average True Range (ATR) | 0.42 | 0.15 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 19.09 | 77.04 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.